Order Article Reprints

Genovese E, Mirabile M, Rontauroli S, Sartini S, Fantini S, Tavernari L, Maccaferri M, Guglielmelli P, Bianchi E, Parenti S, et al. The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis. Antioxidants. 2022; 11(1):113. https://doi.org/10.3390/antiox11010113

Genovese, Elena, Margherita Mirabile, Sebastiano Rontauroli, Stefano Sartini, Sebastian Fantini, Lara Tavernari, Monica Maccaferri, Paola Guglielmelli, Elisa Bianchi, Sandra Parenti, and et al. 2022. "The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis" Antioxidants 11, no. 1: 113. https://doi.org/10.3390/antiox11010113

Genovese, E., Mirabile, M., Rontauroli, S., Sartini, S., Fantini, S., Tavernari, L., Maccaferri, M., Guglielmelli, P., Bianchi, E., Parenti, S., Carretta, C., Mallia, S., Castellano, S., Colasante, C., Balliu, M., Bartalucci, N., Palmieri, R., Ottone, T., Mora, B., ... on behalf of the Mynerva (MYeloid NEoplasms Research Venture AIRC). (2022). The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis. Antioxidants, 11(1), 113. https://doi.org/10.3390/antiox11010113